Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight in the pharmaceutical and healthcare sector through new training requirements, product blacklisting, and watchlist alerts, while also expanding its pharmacist reserve corps. For Nigerian SMBs in pharma, healthcare, and related distribution, this means stricter compliance expectations and heightened risk of enforcement actions for non-compliant products.
Pharmaceuticals
Healthcare
Importation & Distribution
Clinical Trials
Regulatory Compliance
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery, signaling continued focus on local production and quality standards.
SMBs in pharmaceutical manufacturing and chemistry should anticipate ongoing regulatory emphasis on quality, innovation, and affordability, potentially opening opportunities for compliant local producers.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to strengthen regulatory capacity and service delivery.
This may lead to increased inspections and faster regulatory processes, requiring SMBs to maintain higher compliance standards and engage more with NAFDAC.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC announced new dates for mandatory training on clinical trial regulations, emphasizing compliance for stakeholders involved in clinical research.
SMBs involved in clinical trials or research must ensure their staff attend this training to avoid penalties and maintain eligibility for trial approvals.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, and its products, warning importers, distributors, and healthcare institutions to avoid them.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid regulatory sanctions and product seizures.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on watchlist pending investigation, advising healthcare professionals and retailers to exercise caution.
SMBs in retail, distribution, or healthcare should avoid stocking or using these products until investigations conclude, to mitigate legal and health risks.
Regulatory and Supervisory Guidelines for Bureau De Change Operations in Nigeria 2024 - Lexology
Other
This article discusses regulatory and supervisory guidelines for Bureau De Change operations in Nigeria, likely referencing CBN regulations.
SMBs in the financial services sector, particularly BDCs, should review these guidelines to ensure compliance with CBN requirements and avoid penalties.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export, highlighting requirements and processes.
SMBs in aquaculture and export can use this guide to navigate NEPC registration, potentially expanding into export markets and increasing revenue.
NAFDAC is increasing scrutiny on imported pharmaceuticals and healthcare products, raising compliance risks for importers and distributors.
Mandatory training on clinical trial regulations indicates tighter oversight of research activities, affecting SMBs in biotech and pharma.
The pharmacist reserve group may lead to more frequent inspections and faster regulatory responses, requiring SMBs to be audit-ready.
Blacklisting and watchlist alerts highlight the need for robust supply chain due diligence to avoid sourcing prohibited products.
Guidance on BDC operations and fish farm registration signals opportunities for SMBs in financial services and export agriculture to formalize and expand.
1
Immediately verify your product supply chains against NAFDAC's blacklist and watchlist to ensure no prohibited items are stocked or distributed.
2
Ensure relevant staff attend NAFDAC/NHREC mandatory training on clinical trial regulations if your business is involved in clinical research.
3
Review and update your regulatory compliance procedures to align with NAFDAC's intensified oversight, including regular audits and staff training.
4
For BDC operators, obtain and study the CBN's Regulatory and Supervisory Guidelines for Bureau De Change Operations 2024 to ensure full compliance.
5
For fish farmers and exporters, initiate or complete registration with NEPC to access export opportunities and avoid regulatory hurdles.